Enzoglaz Forte Tablet is a combination medication that belongs to a class of medication called 'analgesic' used to relieve musculoskeletal pain in the conditions of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Pain is caused by damage to the tissues of the muscle, bone, or other organs for a short time (acute) or long time (chronic).  

Enzoglaz Forte Tablet is a combination of one antioxidant (Rutoside) and two enzymes (Trypsin and Bromelain). Rutoside is an antioxidant that prevents cell damage, reduces toxins, protects the body from damage caused by free radicals (toxins), and decreases swelling. Trypsin removes dead skin cells and allows the growth of healthy tissue. On the other hand, Bromelain is a pineapple extract limiting fibrin formation by reducing clots or plaque at the damaged/injured site. Together it reduces swelling and inflammation by producing substances in the body against pain and swelling. Thus, Enzoglaz Forte Tablet helps in relieving edema (fluid overload), inflammation and promotes wound healing. 

Take Enzoglaz Forte Tablet with or without food as prescribed by your doctor and swallow whole with a glass of water. Do not crush, chew or break it. Your doctor will advise you how often you take your tablets based on your medical condition. In some cases, you may experience vomiting, nausea, diarrhea, rash, or mouth sores. Most of these side effects of Enzoglaz Forte Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Enzoglaz Forte Tablet or any other medicines, please tell your doctor. Avoid Enzoglaz Forte Tablet in patients who are allergic to pineapple, carrot, papaya, fennel, and pollens. Enzoglaz Forte Tablet is not recommended for pregnant women as it contains Bromelain, which may cause abortion or miscarriage. If you are pregnant or planning for pregnancy, please consult a doctor before taking Enzoglaz Forte Tablet . Before undergoing any planned surgery, inform your doctor that you are taking Enzoglaz Forte Tablet . It should be stopped a minimum of 2 weeks before surgery due to increased bleeding risk during and after surgery. If you have blood pressure problems, clotting or bleeding problems, infection, hematuria (blood in urine), hematemesis (vomiting blood), kidney or liver disorders, inform your doctor before taking Enzoglaz Forte Tablet .

Enzoglaz Forte Tablet is a combination of one antioxidant (Rutoside) and two enzymes (Trypsin, Bromelain). Rutoside is an antioxidant (substances that prevent damage to cells) that works by protecting the body from damage caused by free radicals (unstable molecules produced by the body) and further decreases swelling. Trypsin removes dead skin cells and allows the growth of healthy tissue. In combination with Bromelain, Trypsin reduces swelling and inflammation by producing substances in the body against pain and swelling in the conditions of joint disorders like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.  

If you are allergic to Enzoglaz Forte Tablet or any other medicines, please tell your doctor. People allergic to pineapple, carrot, papain, fennel, and pollen should avoid the intake of Enzoglaz Forte Tablet . It is not recommended for pregnant women as it contains Bromelain, which may cause miscarriage, so if you are pregnant or planning for pregnancy, let your doctor know about this. If you are about to undergo any surgery, inform your doctor that you are taking Enzoglaz Forte Tablet . It should be stopped a minimum of 2 weeks before surgery as Enzoglaz Forte Tablet may increase the risk of bleeding during and after surgery. If you have blood pressure problems, clotting or bleeding problems, infection, hematuria (blood in urine), hematemesis (vomiting blood), kidney or liver disorders, inform your doctor before taking Enzoglaz Forte Tablet .

Enzoglaz Forte Tablet must not be used by patients with severe inborn bleeding disorders like hemophilia, severe liver damage, and dialyzed patients.